Please try another search
Kyorin Pharmaceutical Co Ltd, formerly Kyorin Holdings Inc, is a Japan-based company mainly engaged in the pharmaceuticals business. The Pharmaceuticals segment is mainly engaged in the manufacture, purchase, sales and testing of pharmaceutical products, the purchase of raw materials for pharmaceuticals, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, the operations related to clinical trials and information gathering such as searching for drug discovery seeds, as well as the drug candidate compound discovery research and compound evaluation business. The Company also conducts the diagnostic businesses and verifies and creates research targets that are directly linked to drug discovery.
Name | Age | Since | Title |
---|---|---|---|
Kenji Akutsu | 67 | 2016 | Senior Corporate Auditor |
Tomiharu Matsumoto | 70 | 2018 | Chairman of Corporate Auditors |
Michiro Onota | 63 | 2017 | Executive Director & CMO |
Takao Yamaguchi | 69 | - | Outside Member of Audit & Supervisory Board |
Noriyuki Shikanai | 75 | 2013 | Independent Outside Director |
Hiromi Watanabe | 76 | 2019 | Independent Outside Director |
Kensuke Morita | 57 | 2022 | Outside Audit & Supervisory Board Member |
Ken Shigematsu | 75 | 2017 | Independent Outside Director |
Yukio Ikemura | 65 | 2022 | Outside Audit & Supervisory Board Member |
Hiroshi Hashizume | - | 2018 | Executive Officer, President & Representative Director of Kyorin Rimedio Co., Ltd. |
Yutaka Ogihara | 57 | 2011 | President, CEO & Representative Director |
Yasuji Kurose | - | 2024 | CFO, CStO, Director of Corporate Planning & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review